Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pediatr Emerg Care ; 35(12): e229-e231, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31790071

RESUMEN

Kawasaki disease is an acute vasculitis syndrome that typically occurs in children aged 1 to 4 years. Because there is no specific diagnostic test for Kawasaki disease, the diagnosis is made clinically based on specific characteristic signs and symptoms. Cases in which patients fall outside of the typical age range are uncommon and often challenging to diagnose because they have atypical presentations. This is especially true in infants, who rarely meet all the clinical criteria required for diagnosis. Patients at the extremes of ages often have a delayed diagnosis, which can lead to worse cardiac outcomes. We describe the cases of a young infant and an older adolescent who present with Kawasaki disease. These cases illustrate the challenge of diagnosing Kawasaki disease in patients beyond the typical age range. Both patients were return visits to the emergency department after inpatient stays. When fever persists longer than 5 days, clinicians must have a high index of suspicion for Kawasaki disease in all pediatric age groups to prevent treatment delay and disease sequelae.


Asunto(s)
Exantema/etiología , Fiebre/etiología , Síndrome Mucocutáneo Linfonodular/diagnóstico por imagen , Síndrome Mucocutáneo Linfonodular/patología , Administración Intravenosa , Adolescente , Aneurisma/patología , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/uso terapéutico , Artralgia/etiología , Aspirina/administración & dosificación , Aspirina/uso terapéutico , Anomalías de los Vasos Coronarios/diagnóstico por imagen , Anomalías de los Vasos Coronarios/patología , Ecocardiografía/métodos , Servicio de Urgencia en Hospital , Exantema/diagnóstico , Femenino , Fiebre/diagnóstico , Fístula/patología , Humanos , Inmunoglobulinas/administración & dosificación , Inmunoglobulinas/uso terapéutico , Factores Inmunológicos/administración & dosificación , Factores Inmunológicos/uso terapéutico , Lactante , Masculino , Síndrome Mucocutáneo Linfonodular/tratamiento farmacológico
2.
Pediatr Ann ; 52(5): e187-e191, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-37159065

RESUMEN

Electronic cigarette and vaping device use in the household represents a possible source of unintentional nicotine exposure to pediatric patients. Although most ingestions of nicotine may be mild, there is a potential for significant toxicity. Nicotine toxicity can present similarly to many other types of ingestions, which makes the history an important piece of the encounter. Treatment of nicotine toxicity is primarily supportive care directed at the presenting signs and symptoms. There is no antidotal therapy for nicotine toxicity. This review covers information that can assist clinicians who might treat a pediatric patient presenting with significant nicotine toxicity after the accidental ingestion of liquid nicotine products. [Pediatr Ann. 2023;52(5):e187-e191.].


Asunto(s)
Sistemas Electrónicos de Liberación de Nicotina , Vapeo , Humanos , Niño , Nicotina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA